ACAD
26.02
-0.25
-0.95%
AEMD
1.874
+0.064
+3.5193%
APRI
0.95
-0.01
-1.04%
ARNA
1.31
-0.05
-3.68%
ATEC
1.99
-0.04
-1.97%
CNAT
5.17
-0.09
-1.71%
CRXM
0.161
-0.009
-5.4118%
CYTX
1.03
0.00
0.00%
DXCM
68.65
-0.5
-0.72%
GNMK
13.14
+0.14
+1.08%
HALO
12.41
-0.19
-1.51%
ILMN
175.91
+2.15
+1.24%
INNV
0.133
+0.015
+12.807%
INO
7.88
-0.11
-1.38%
ISCO
1.32
-0.17
-11.41%
ISIS
57.56
0.00
0.00%
LGND
110.19
-3.31
-2.92%
LPTN
2.93
-0.08
-2.66%
MBVX
1.66
-0.13
-7.26%
MEIP
2.12
+0.15
+7.61%
MNOV
5.95
-0.1
-1.65%
MRTX
3.25
-0.05
-1.52%
MSTX
0.131
-0.007
-5.278%
NBIX
46.22
-2.42
-4.99%
NUVA
75.52
-0.26
-0.34%
ONCS
1.06
+0.08
+8.16%
ONVO
2.94
+0.09
+3.16%
OREX
2.97
+0.03
+1.02%
OTIC
12.35
-0.3
-2.37%
QDEL
24.91
-0.01
-0.04%
RCPT
231.96
0.00
0.00%
RGLS
1.375
+0.025
+1.852%
RMD
70.07
+0.02
+0.03%
SCIE
0.001
+0.00
+16.6667%
SPHS
2.46
-0.01
-0.40%
SRNE
1.75
+0.1
+6.06%
TROV
0.651
-0.039
-5.6377%
VICL
2.36
0.00
0.00%
VOLC
18
0.00
0.00%
ZGNX
12.65
-0.25
-1.94%
ACAD
26.02
-0.25
-0.95%
AEMD
1.874
+0.064
+3.5193%
APRI
0.95
-0.01
-1.04%
ARNA
1.31
-0.05
-3.68%
ATEC
1.99
-0.04
-1.97%
CNAT
5.17
-0.09
-1.71%
CRXM
0.161
-0.009
-5.4118%
CYTX
1.03
0.00
0.00%
DXCM
68.65
-0.5
-0.72%
GNMK
13.14
+0.14
+1.08%
HALO
12.41
-0.19
-1.51%
ILMN
175.91
+2.15
+1.24%
INNV
0.133
+0.015
+12.807%
INO
7.88
-0.11
-1.38%
ISCO
1.32
-0.17
-11.41%
ISIS
57.56
0.00
0.00%
LGND
110.19
-3.31
-2.92%
LPTN
2.93
-0.08
-2.66%
MBVX
1.66
-0.13
-7.26%
MEIP
2.12
+0.15
+7.61%
MNOV
5.95
-0.1
-1.65%
MRTX
3.25
-0.05
-1.52%
MSTX
0.131
-0.007
-5.278%
NBIX
46.22
-2.42
-4.99%
NUVA
75.52
-0.26
-0.34%
ONCS
1.06
+0.08
+8.16%
ONVO
2.94
+0.09
+3.16%
OREX
2.97
+0.03
+1.02%
OTIC
12.35
-0.3
-2.37%
QDEL
24.91
-0.01
-0.04%
RCPT
231.96
0.00
0.00%
RGLS
1.375
+0.025
+1.852%
RMD
70.07
+0.02
+0.03%
SCIE
0.001
+0.00
+16.6667%
SPHS
2.46
-0.01
-0.40%
SRNE
1.75
+0.1
+6.06%
TROV
0.651
-0.039
-5.6377%
VICL
2.36
0.00
0.00%
VOLC
18
0.00
0.00%
ZGNX
12.65
-0.25
-1.94%
Home » Archive by Category

Xconomy

Ionis Pharma Spins Out Lipid Disorder Unit Akcea with Plans for IPO

March 27, 2017 – 7:35 am

Akcea Therapeutics, an Ionis Pharmaceuticals subsidiary focused on rare lipid disorders, is spinning out of its parent with plans for an initial public stock offering as it prepares to file for FDA…

[[Click headline to continue reading.]]

Bio Roundup: Trumpcare Wavers, Amgen Courts Payers, Critics Circle PTC

March 24, 2017 – 3:25 am

Who knew healthcare could be so complicated? This week, President Trump and the GOP saw first hand, as a feverish rally to get their healthcare bill through the House of Representatives on Thursday…

[[Click headline to continue reading.]]

Today Only: Save $70 for Human Impact of Innovation on April 19th

March 23, 2017 – 2:45 am

Xconomy is convening life sciences and technology founders, executives, investors, and entrepreneurs for an afternoon of fireside chats and solo talks at Human Impact of Innovation. A few topics…

[[Click headline to continue reading.]]

Amid Gender Gap Talk, Mentor Network Emerges For Women In Health, Bio

March 23, 2017 – 2:30 am

It’s been more than a year since an infamous party with hired models in cocktail dresses captured the biotech community’s attention at the 2016 J.P. Morgan conference. There has been…

[[Click headline to continue reading.]]

Join David Baltimore, Nicole Glaros, Nathan Myhrvold, & More at Our Napa Summit

March 22, 2017 – 3:15 am

Year after year, Xconomy has gathered exemplary business leaders, investors, and far-seeing technologists to our most prestigious event—The Napa Summit. This year is no different. Come join us…

[[Click headline to continue reading.]]

Waving White Flag, Cerulean Merges With Dare Bio, Sells Cancer Drugs

March 20, 2017 – 6:41 am

Cerulean Pharma may have been able to survive one brush with death, but the second has proven fatal. Today, the Waltham, MA, company announced plans to merge with a privately held women’s health…

[[Click headline to continue reading.]]

With New Data, Amgen Promises Refund If Cholesterol Drug Doesn’t Work

March 17, 2017 – 4:55 am

Stung by slow sales of its next-generation anti-cholesterol drug, Amgen hopes new clinical data, released this morning, will spur doctors to boost prescriptions and—perhaps more…

[[Click headline to continue reading.]]

Bio Roundup: Trump Budget, FDA Chief, CAR-T Qs, CRISPR Cash, & More

March 17, 2017 – 2:50 am

If it wasn’t clear that the Trump administration disdained most types of scientific inquiry and practice, the White House’s proposed budget drove the point home. The top-line figures: a…

[[Click headline to continue reading.]]

CRISPR Organs? eGenesis Raises $38M For Pig-To-Human Transplants

March 15, 2017 – 9:38 pm

One of the companies trying to revive the once-failed notion of xenotransplantation—transplanting animal organs or tissues into humans—has raised a significant round of cash. The $38…

[[Click headline to continue reading.]]

Human Longevity Offers Genome Sequencing Through MassMutual

March 14, 2017 – 9:00 pm

Human Longevity Inc., founded in 2014 by the gene pioneer J. Craig Venter to create a database for interpreting the human genome (and to make healthcare more proactive instead of reactive) said it…

[[Click headline to continue reading.]]